×

ENTER REPORT NAME TO SEARCH

Global Nuclear Medicine Diagnostics Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS1437 | Category: Healthcare | Pages: 107 | Format: PDF | Published Date: August 16,2023


Table of Contents

Table of Content

1 Nuclear Medicine Diagnostics Market Overview
1.1 Nuclear Medicine Diagnostics Product Overview
1.1.1 Nuclear Medicine Diagnostics Product Scope
1.1.2 Nuclear Medicine Diagnostics Market Status and Outlook
1.2 Global Nuclear Medicine Diagnostics Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Nuclear Medicine Diagnostics Market Size by Region (2018-2029)
1.4 Global Nuclear Medicine Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Nuclear Medicine Diagnostics Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.1 North America Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.2 Europe Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.4 Latin America Nuclear Medicine Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Nuclear Medicine Diagnostics Market Size (2018-2029)
2 Nuclear Medicine Diagnostics Market Overview by Type
2.3 Global Nuclear Medicine Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Nuclear Medicine Diagnostics Historic Market Size by Type (2018-2023)
2.5 Global Nuclear Medicine Diagnostics Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Nuclear Medicine Diagnostics Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Nuclear Medicine Diagnostics Market Size Breakdown by Type
2.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size Breakdown by Type
2.6.4 Latin America Nuclear Medicine Diagnostics Market Size Breakdown by Type
2.6.5 Middle East and Africa Nuclear Medicine Diagnostics Market Size Breakdown by Type
3 Nuclear Medicine Diagnostics Market Overview by Application
3.3 Global Nuclear Medicine Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Nuclear Medicine Diagnostics Historic Market Size by Application (2018-2023)
3.5 Global Nuclear Medicine Diagnostics Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Nuclear Medicine Diagnostics Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Nuclear Medicine Diagnostics Market Size Breakdown by Application
3.6.3 Asia-Pacific Nuclear Medicine Diagnostics Market Size Breakdown by Application
3.6.4 Latin America Nuclear Medicine Diagnostics Market Size Breakdown by Application
3.6.5 Middle East and Africa Nuclear Medicine Diagnostics Market Size Breakdown by Application
4 Nuclear Medicine Diagnostics Competition Analysis by Players
4.1 Global Nuclear Medicine Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine Diagnostics as of 2022)
4.3 Date of Key Players Enter into Nuclear Medicine Diagnostics Market
4.4 Global Top Players Nuclear Medicine Diagnostics Headquarters and Area Served
4.5 Key Players Nuclear Medicine Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Nuclear Medicine Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Nuclear Medicine Diagnostics Market Segment by Country
5.1 North America Nuclear Medicine Diagnostics Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Nuclear Medicine Diagnostics Market Segment by Country
6.1 Europe Nuclear Medicine Diagnostics Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Nuclear Medicine Diagnostics Market Segment by Country
7.1 Asia-Pacific Nuclear Medicine Diagnostics Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Nuclear Medicine Diagnostics Market Segment by Country
8.1 Latin America Nuclear Medicine Diagnostics Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Nuclear Medicine Diagnostics Market Segment by Country
9.1 Middle East & Africa Nuclear Medicine Diagnostics Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Cardinal Health (U.S.)
10.1.1 Cardinal Health (U.S.) Information
10.1.2 Business Overview
10.1.3 Cardinal Health (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.1.4 Nuclear Medicine Diagnostics Products Offered
10.1.5 Cardinal Health (U.S.) Recent Development
10.2  General Electric (U.S.)
10.2.1 General Electric (U.S.) Information
10.2.2 Business Overview
10.2.3 General Electric (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.2.4 Nuclear Medicine Diagnostics Products Offered
10.2.5 General Electric (U.S.) Recent Development
10.3  Lantheus (U.S.)
10.3.1 Lantheus (U.S.) Information
10.3.2 Business Overview
10.3.3 Lantheus (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.3.4 Nuclear Medicine Diagnostics Products Offered
10.3.5 Lantheus (U.S.) Recent Development
10.4  Bayer AG (Germany)
10.4.1 Bayer AG (Germany) Information
10.4.2 Business Overview
10.4.3 Bayer AG (Germany) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.4.4 Nuclear Medicine Diagnostics Products Offered
10.4.5 Bayer AG (Germany) Recent Development
10.5  Bracco Diagnostic Inc. (Italy)
10.5.1 Bracco Diagnostic Inc. (Italy) Information
10.5.2 Business Overview
10.5.3 Bracco Diagnostic Inc. (Italy) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.5.4 Nuclear Medicine Diagnostics Products Offered
10.5.5 Bracco Diagnostic Inc. (Italy) Recent Development
10.6  NorthStar Medical Radioisotopes, LLC (U.S.)
10.6.1 NorthStar Medical Radioisotopes, LLC (U.S.) Information
10.6.2 Business Overview
10.6.3 NorthStar Medical Radioisotopes, LLC (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.6.4 Nuclear Medicine Diagnostics Products Offered
10.6.5 NorthStar Medical Radioisotopes, LLC (U.S.) Recent Development
10.7  Eckert & Ziegler. (Germany)
10.7.1 Eckert & Ziegler. (Germany) Information
10.7.2 Business Overview
10.7.3 Eckert & Ziegler. (Germany) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.7.4 Nuclear Medicine Diagnostics Products Offered
10.7.5 Eckert & Ziegler. (Germany) Recent Development
10.8  Jubilant DraxImage, Inc. (Canada)
10.8.1 Jubilant DraxImage, Inc. (Canada) Information
10.8.2 Business Overview
10.8.3 Jubilant DraxImage, Inc. (Canada) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.8.4 Nuclear Medicine Diagnostics Products Offered
10.8.5 Jubilant DraxImage, Inc. (Canada) Recent Development
10.9  PharmaLogic Holdings Corp. (U.S.)
10.9.1 PharmaLogic Holdings Corp. (U.S.) Information
10.9.2 Business Overview
10.9.3 PharmaLogic Holdings Corp. (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.9.4 Nuclear Medicine Diagnostics Products Offered
10.9.5 PharmaLogic Holdings Corp. (U.S.) Recent Development
10.10  Institute of Isotopes Co., Ltd (Hungary)
10.10.1 Institute of Isotopes Co., Ltd (Hungary) Information
10.10.2 Business Overview
10.10.3 Institute of Isotopes Co., Ltd (Hungary) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.10.4 Nuclear Medicine Diagnostics Products Offered
10.10.5 Institute of Isotopes Co., Ltd (Hungary) Recent Development
10.11  SHINE Medical Technologies, LLC (U.S.)
10.11.1 SHINE Medical Technologies, LLC (U.S.) Information
10.11.2 Business Overview
10.11.3 SHINE Medical Technologies, LLC (U.S.) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.11.4 Nuclear Medicine Diagnostics Products Offered
10.11.5 SHINE Medical Technologies, LLC (U.S.) Recent Development
10.12  Global Medical Solutions LLC (China)
10.12.1 Global Medical Solutions LLC (China) Information
10.12.2 Business Overview
10.12.3 Global Medical Solutions LLC (China) Nuclear Medicine Diagnostics Revenue, Gross Margin
10.12.4 Nuclear Medicine Diagnostics Products Offered
10.12.5 Global Medical Solutions LLC (China) Recent Development
11 Nuclear Medicine Diagnostics Market Dynamics
11.1 Nuclear Medicine Diagnostics Industry Trends
11.2 Nuclear Medicine Diagnostics Growth Drivers
11.3 Nuclear Medicine Diagnostics Market Challenges
11.4 Nuclear Medicine Diagnostics Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

It contains all the geographic trends, and market analysis for global market